Myhre, BA. The first recorded blood transfusions: 1656–1688. Transfusion 1990;30:358-62.10.1046/j.1537-2995.1990.30490273445.x2190368Search in Google Scholar
Myhre BA. James Blundell—pioneer transfusionist. Transfusion 1995;35:74-8.10.1046/j.1537-2995.1995.35195090668.x7998076Search in Google Scholar
Oberman HA. The crossmatch. A brief historical perspective. Transfusion 1981;21:645-51.10.1046/j.1537-2995.1981.21682085750.x6797110Search in Google Scholar
Crile GW. Hemorrhage and Transfusion. New York: D. Appleton & Co., 1909:318.Search in Google Scholar
Hektoen L. Isoagglutination of human corpuscles. JAMA 1907;48:1739.10.1001/jama.1907.25220470007001bSearch in Google Scholar
Ottenberg R. Transfusion and arterial anastamosis. Am J Surg 1908;47:486.Search in Google Scholar
Epstein AA, Ottenberg R. A method for hemolysis and agglutinin tests. Arch Intern Med 1909;3:286.Search in Google Scholar
Moss, WL. Studies on isoagglutination and isohemolysis. Bull J Hopk Hosp 1910;21:63.Search in Google Scholar
Lee RI. A simple and rapid method for the selection of suitable donors for transfusion by the determination of blood groups. Br Med J 1917; 2:684.10.1136/bmj.2.2969.684234949520768818Search in Google Scholar
Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pretranfusion platelet compatibility testing, Am J Clin Pathol 1988;90:63-8.10.1093/ajcp/90.1.633389344Search in Google Scholar
Diamond LK, Denton RL. Rh agglutination in various media with particular reference to the value of albumin. J Lab Clin Med 1945;30:821.Search in Google Scholar
Coombs RR, Mourant AE, Race R.A new test for the detection of weak and “incomplete” Rh agglutinins. Br J Exp Pathol 1945;26:255-66.10.1007/978-94-011-6138-1_10Search in Google Scholar
Bishop JF, Matthews JP,Yuen K, et al. The definition of refractoriness to platelet transfusions. Transfus Med 1992;2:35-41.10.1111/j.1365-3148.1992.tb00132.x1308461Search in Google Scholar
Bishop JF, McGrath K, Wolf MM, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988;71:383-7.10.1182/blood.V71.2.383.383Search in Google Scholar
Yankee RA, Grumet FC, Rogentine GN. Platelet transfusion. The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 1969;281:1208-12.10.1056/NEJM1969112728122025347838Search in Google Scholar
Duquesnoy RJ, Filip DJ, Rodey GE, et al. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977;2:219-26.10.1002/ajh.2830020303Search in Google Scholar
Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363-9.10.1002/ajh.2830140407Search in Google Scholar
McFarland JG, Anderson AJ, Slichter SJ. Factors inf luencing the transfusion response to HLA- selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989;73:380-6.10.1111/j.1365-2141.1989.tb07757.xSearch in Google Scholar
Phekoo KJ, Hambley H, Schey SA, et al. Audit of practice in platelet refractoriness. Vox Sang 1997;73:81-6.10.1159/000461911Search in Google Scholar
Engelfriet CP, Reesink HW, Aster RH, et al. Management of alloimmunized, refractory patients in need of platelet transfusions. Vox Sang 1997;73:191-8.10.1046/j.1423-0410.1997.73301911.xSearch in Google Scholar
Murphy S, Varma M. Selecting platelets for transfusion of the alloimmunized patient: A review. Immunohematology 1998;14:117-23.10.21307/immunohematology-2019-675Search in Google Scholar
Duquesnoy RJ. HLA Matchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 202;63:339-52.10.1016/S0198-8859(02)00382-8Search in Google Scholar
Duquesnoy RJ, Marrari M. HLA Matchmaker: A molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 202;63:353-63.10.1016/S0198-8859(02)00381-6Search in Google Scholar
Gelb AB, Leavitt AD. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 1997;37:624-30.10.1046/j.1537-2995.1997.37697335157.x9191823Search in Google Scholar
Petz LD, Garratty G, Calhoun L, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 200;40:1446-56.10.1046/j.1537-2995.2000.40121446.x11134563Search in Google Scholar
Lee EJ, Schiffer CA. Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients. Blood 1987;70:1727-9.10.1182/blood.V70.6.1727.1727Search in Google Scholar
Terasaki PI, Marchioro TL, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. In: Histocompatibility Testing. Report of a Conference and Workshop. Washington DC: National Academy of Sciences—National Research Council 1965: 83-96.Search in Google Scholar
Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966;2(7465):662-5.10.1016/S0140-6736(66)92829-7Search in Google Scholar
Terasaki PI. Humoral theory of transplantation. Am J Transplant 203;3:665-73.10.1034/j.1600-6143.2003.00135.xSearch in Google Scholar
Rodey G. HLA beyond tears: introduction to human histocompatibility. 2nd ed. Durango, CO: De Novo, Inc., 200: Chapters 4, 8, 9 and 10.Search in Google Scholar
Rodey GE, Revels K, Fuller TC. Epitope specificity of HLA Class I alloantibodies. II. Stability of crossreactive group antibody patterns over extended time periods. Transplantation 1997;63:885-93.10.1097/00007890-199703270-00015Search in Google Scholar
Rodey GE, Neylan JF, Whelchel JD, et al. Epitope specificity of HLA Class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994;39:272-80.10.1016/0198-8859(94)90270-4Search in Google Scholar
Meny GM, Hsu S, Murphy S, Pei R. ELISA and flow cytometr y provide advantages over lympho- cytotoxicity in detecting HLA antibodies. (In preparation) 204.Search in Google Scholar
Scornik JC, Ireland JE, Howard RJ, Pfaff WW. Assessment of the risk for broad sensitization by blood transfusions. Transplantation 1984;37: 249-53.10.1097/00007890-198403000-00006Search in Google Scholar
Braun, W.E. Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches. Clin Lab Med 1991:11:571-602.10.1016/S0272-2712(18)30542-0Search in Google Scholar
Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204: 998-100.10.1038/204998b014248725Search in Google Scholar
Amos DB, Bashir H, Boyle W, et al. A simple micro cytotoxicity test. Transplantation 1969;7:220-3.10.1097/00007890-196903000-000235779102Search in Google Scholar
Johnson AH, Rossen RD, Butler WT. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection. Tissue Antigens 1972;2:215-26.10.1111/j.1399-0039.1972.tb00138.x4586478Search in Google Scholar
Fuller TC, Fuller AA, Golden M, Rodey GE. HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure. Hum Immunol 1997;56:94-105.10.1016/S0198-8859(97)00174-2Search in Google Scholar
Yunis EJ, Ward FE, Amos DB. Observations on the CYNAP phenomenon. In: Terasaki PI, ed. Histocompatibility 1970. Copenhagen: Munksgaard, 1970:351-6.Search in Google Scholar
Kao KJ, Scornik JC, Small SJ. Enzyme-linked immunoassay for anti-HLA antibodies—an alternative to panel studies by lymphocytotoxicity. Transplantation 1993;55:192-6.10.1097/00007890-199301000-00036Search in Google Scholar
Wang G, Tarsitani C, Denham S, Chen M, Lee J-H. A new micro-ELISA for anti-Class I and Class II antibody detection. Human Immunol 1998:59(1): 133.Search in Google Scholar
Garovoy MR, Rheinschmidt MA, Bigos M, et al. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation. Transplant Proc 1983;15:1939-44.Search in Google Scholar
Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA Class I and Class II antibodies screening with f low cytometry. Human Immunol 1998;59:313-22.10.1016/S0198-8859(98)00020-2Search in Google Scholar
Pei R, Lee J, Chen T, et al. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999;60:1293-1302.10.1016/S0198-8859(99)00121-4Search in Google Scholar
Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen f low cytometr y beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 203;75:43-9.10.1097/00007890-200301150-0000812544869Search in Google Scholar
Visuals of the Clinical Histocompatibility Workshop, Cancun, Mexico 202, Hawaii 203, sponsored by One Lambda, Inc. Paul Terasaki, Ed.Search in Google Scholar
Tambur AR, Bray RA, Takeomoto SK, et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 200;70:1055-9.10.1097/00007890-200010150-0001111045642Search in Google Scholar
Gebel HM, Bray RA. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 200;69:1370-4.10.1097/00007890-200004150-0002710798756Search in Google Scholar
Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 203;3: 1488-1500.10.1046/j.1600-6135.2003.00273.x14629279Search in Google Scholar
